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RESEARCH ARTICLE
Tyrosine phosphorylation of WIP releases bound WASP and
impairs podosome assembly in macrophages
Vineetha Vijayakumar1,`, James Monypenny1,`, Xing Judy Chen1, Laura M. Machesky2, Sergio Lilla2,
Adrian J. Thrasher3, Ine´s M. Anto´n4, Yolanda Calle5,* and Gareth E. Jones1,§
ABSTRACT
Podosomes are integrin-containing adhesion structures commonly
found in migrating leukocytes of the monocytic lineage. The actin
cytoskeletal organisation of podosomes is based on a WASP- and
Arp2/3-mediated mechanism. WASP also associates with a second
protein, WIP (also known as WIPF1), and they co-localise in
podosome cores. Here, we report for the first time that WIP can
be phosphorylated on tyrosine residues and that tyrosine
phosphorylation of WIP is a trigger for release of WASP from the
WIP–WASP complex. Using a knockdown approach together with
expression of WIP phosphomimics, we show that in the absence of
WIP–WASP binding, cellular WASP is rapidly degraded, leading to
disruption of podosomes and a failure of cells to degrade an
underlying matrix. In the absence of tyrosine phosphorylation, the
WIP–WASP complex remains intact and podosome lifetimes are
extended. A screen of candidate kinases and inhibitor-based
assays identified Bruton’s tyrosine kinase (Btk) as a regulator
of WIP tyrosine phosphorylation. We conclude that tyrosine
phosphorylation of WIP is a crucial regulator of WASP stability
and function as an actin-nucleation-promoting factor.
KEY WORDS: WIP, WIPF1, Tyrosine phosphorylation, Podosome,
Actin cytoskeleton, Macrophages, Matrix degradation
INTRODUCTION
Adhesion and migration of monocyte-derived cells is regulated
by actin-rich integrin-containing structures termed podosomes
(Calle et al., 2006; Linder and Aepfelbacher, 2003). The rapid
formation and turnover of podosomes during migration is
dependent upon the actions of the Wiskott–Aldrich syndrome
protein (WASP) (Calle et al., 2004b; Calle et al., 2004a), a key
regulator of Arp2/3-dependent de novo actin polymerisation
(Millard et al., 2004). In cells, WASP is associated with the
WASP-interacting protein (WIP, also known as WIPF1) (Stewart
et al., 1999; Ramesh et al., 1997), a multifunctional adaptor
implicated in a wide range of cellular functions, including cell
adhesion, migration and chemotaxis, T-cell activation and
proliferation, and intracellular pathogen motility (Anton and
Jones, 2006; Anto´n et al., 2007; Moreau et al., 2000). WIP
functions through binding to both globular and filamentous actin
(Martinez-Quiles et al., 2001) and several regulators of actin
dynamics (Anto´n et al., 1998). WIP can also bind to and regulate
the function of the actin-nucleation-promoting factor cortactin
(Kinley et al., 2003; Ban˜o´n-Rodrı´guez et al., 2011). In cells of
haematopoietic origin, WIP is an important regulator of WASP,
the expression of which is restricted to cells of this lineage.
WASP is indispensable for normal leukocyte function and its
importance is highlighted in the congenital disorder Wiskott–
Aldrich syndrome in which missense mutations in the WAS gene
result in severe immunodeficiency (Derry et al., 1994; Ochs and
Thrasher, 2006; Thrasher and Burns, 2010).
WIP regulates WASP expression levels by binding to and
protecting WASP from calpain- and/or proteasome-mediated
degradation (Blundell et al., 2009; Chou et al., 2006; de la Fuente
et al., 2007; Macpherson et al., 2012). Under resting conditions,
the majority of WASP forms a complex with WIP, and any
unbound WASP is rapidly targeted for degradation (Tsuboi,
2007; Konno et al., 2007; Macpherson et al., 2012). Given the
crucial role of WASP in immune cell function, it is unsurprising
that mutations in WASP which impair or abolish WIP binding
result in immunological disorders of varying severity (Kim et al.,
2004; Stewart et al., 1999). WIP-null mouse dendritic cells
exhibit defects in polarity, chemotaxis and cytoskeletal
organisation (Ban˜o´n-Rodrı´guez et al., 2011; Chou et al., 2006),
phenotypes reminiscent of those found for WASP-null dendritic
cells (Burns et al., 2001; Calle et al., 2004a) and macrophages
(Jones et al., 2002; Zicha et al., 1998). Importantly, WIP and
WASP are essential for the assembly and turnover of podosomes,
actin-rich adhesions implicated in the invasion and matrix
remodelling of professional migratory cells such as
macrophages, dendritic cells and osteoclasts (Calle et al.,
2004b; Chabadel et al., 2007). Macrophages and dendritic cells
from WAS patients fail to form podosomes and this is likely to be
a major contributing factor to the defective trafficking and
immune surveillance of these cells that are characteristic of this
disease (Bouma et al., 2009; Burns et al., 2004; Jones et al., 2002;
Thrasher, 2002).
Although the ability of WIP to protect WASP from proteolytic
degradation is vital for WASP function in podosome formation,
WIP has also been shown to contribute directly to the regulation
of these structures, targeting WASP to sites of podosome
assembly (Chou et al., 2006). Mechanisms that control WIP–
WASP interaction are therefore crucial for the regulation of
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podosome function and consequently normal leukocyte biology
as they influence both WASP localisation and turnover. However,
the nature of the regulatory mechanisms that control WIP
function has remained elusive. Phosphorylation represents a
strong candidate for regulation of WIP function, as studies have
reported serine/threonine phosphorylation of WIP on a number of
residues (Dong et al., 2007; Krzewski et al., 2006; Sasahara et al.,
2002; Shu et al., 2004). Of these, only S488 had been the basis of
any functional study (Dong et al., 2007; Krzewski et al., 2006;
Sasahara et al., 2002), it being reported to be phosphorylated in a
PKCh-dependent manner in response to T-cell receptor activation
(Sasahara et al., 2002). S488 lies immediately downstream of the
WASP-binding domain (WBD) of WIP (amino acids 451–485)
(Volkman et al., 2002; Zettl and Way, 2002) and it was originally
proposed that phosphorylation of this residue results in
dissociation of the WIP–WASP complex (Sasahara et al.,
2002). However, subsequent studies in both Jurkat cells (Dong
et al., 2007) and the YTS natural killer cell line (Krzewski et al.,
2006) have demonstrated that WIP and WASP can remain bound
together following phosphorylation of this residue, and the
functional significance of this phosphorylation event has only
recently been addressed (Fried et al., 2014).
In this study, we provide evidence for tyrosine phosphorylation
of WIP as a mechanism for disrupting WIP–WASP association.
We demonstrate that phosphomimetic but not unphosphorylatable
mutations of tyrosine residues within the WBD of WIP abolish
WASP binding, fail to protect WASP from degradation, and are
defective in their ability to rescue podosome formation and
their matrix degradation properties when expressed in WIP-
knockdown cells. Conversely, expression of wild-type and
unphosphorylatable mutants in WIP-knockdown cells results
in the restoration of podosomes and matrix degradation.
Unequivocal confirmation of the phosphorylation of tyrosine
residues within the WBD of WIP was provided by mass
spectroscopy. A screen of candidate tyrosine kinases and
subsequent small molecule inhibitor and kinase assays
identified Bruton’s tyrosine kinase (Btk) as an effector of WIP
tyrosine phosphorylation. Taken together, our findings provide
evidence for tyrosine phosphorylation of WIP as a mechanism for
regulating WIP–WASP association and podosome function in
cells of the monocytic lineage.
RESULTS
Putative serine/threonine phosphorylation sites in WIP do not
regulate WIP–WASP association
A number of studies have reported serine/threonine phosphorylation
of WIP at residues that lie either within or adjacent to the NCK- and
WASP-binding domains (Fig. 1A, yellow residues). NCK is an
ubiquitous adaptor molecule known to contribute towards
N-WASP–WASP activation and release of its auto-inhibited
conformation (Rohatgi et al., 2001). PKCh-dependent
phosphorylation of S488 of WIP in response to T-cell receptor
activation has been demonstrated in Jurkat T-cells (Dong et al.,
2007), but increasing evidence indicates that this is not associated
with disruption of the WIP–WASP complex as previously proposed
(Sasahara et al., 2002). In the monocytic THP-1 cell line, we
demonstrate that WASP is bound to both unphosphorylatable and
phosphomimetic variants of S488 suggesting that phosphorylation
of this residue is not associated with the dissociation of the WIP–
WASP complex in monocytic cells (Fig. 1B). We also set out to
test the ability of other previously suspected phosphorylatable
serine/threonine residues. The expression of two WIP constructs
that confer either unphosphorylatable or phosphomimetic mutations
for five serine/threonine residues (S340, S342, S344, T345 and
S350) previously identified as phosphorylated in proteomic screens
(Shu et al., 2004) were also able to immunoprecipitate WASP.
These results suggest that serine/threonine phosphorylation of WIP,
and in particular phosphorylation of S488, which lies close to the
WBD of WIP, does not disrupt WIP–WASP interaction.
Evidence for phosphorylation of tyrosine residues within the
WBD of WIP in THP-1 cells
Although serine phosphorylation of WIP has been reported,
nothing is currently known about the potential role of tyrosine
phosphorylation in the regulation of WIP function. Human WIP
contains three tyrosine residues, Y455, Y468 and Y475, which lie
in close proximity to one another either within or adjacent to
functionally important regions within the WBD of WIP (Fig. 1A,
green residues).
To determine whether WIP is tyrosine phosphorylated, EGFP-
tagged versions of wild-type WIP [WIP(WT)], the unphosphorylatable
WIP mutants Y455F, Y468F and Y475F, and as the triple
unphosphorylatable mutant Y455F/Y468F/Y475F (Y455/468/
475F) were stably expressed in THP-1 cells following lentiviral
transduction. As negative controls, cells expressing either EGFP or
a WIP truncation mutant lacking residues 450–503 [WIP(DWBD)–
EGFP], comprising the WBD and therefore all tyrosine residues,
were also included. EGFP fusion proteins were immunoprecipitated
from lysates of TGFb1-differentiated THP-1 cells pre-treated with
pervanadate using an anti-GFP antibody. A phosphotyrosine band
corresponding to the size of the WIP–EGFP fusion protein was
clearly observed for cells expressing the wild-type protein
(Fig. 1C). However, the intensity of this band was greatly
diminished for cells expressing either the Y455/468/475F triple
unphosphorylatable mutant or the single Y455F mutant, and was of
similar intensity to that of the WIP(DWBD)–EGFP negative
control. The intensity of the corresponding band for the Y468F and
Y475F mutants was also diminished compared to that of the wild-
type control, but not to the extent observed for the Y455F or Y455/
468/475F triple unphosphorylatable mutants. These findings
indicate that WIP can be phosphorylated at multiple tyrosine
residues and led us to a discovery programme using mass
spectroscopy.
A tryptic digest of pervanadate-treated THP-1 cell lysate
expressing WIP(WT)–EGFP was purified by GFP-TRAP-A
beads, prepared and analysed with mass spectrometry under the
conditions described in the Materials and Methods. The WIP–
EGFP fusion protein sequence was identified with 73 unique
peptides, accounting for 88% of sequence coverage: among
them five unique phosphopeptides were also detected. All
phosphopeptides identified were referred to the sequence of
‘WAS/WASL-interacting protein family member 1’ (WIPF1;
UniProt code O43516) and reported in Table 1. Each
phosphorylation site of WIP was manually validated taking into
account results from Mascot and Andromeda. Phosphorylation of
residues S234, S342, Y468 and Y455 are not reported in Uniprot,
Phosida or Phospho.elm phosphorylation site databases. In our
study, two out of three tyrosine residues present in the WIP
sequence were found to be phosphorylated. The part of the
sequence containing Y475 is included in a tryptic peptide too
small to be detected in the conditions chosen for the analysis.
However, a peptide comprising residues 474–481 containing one
trypsin miscleavage on K478 was detected, but there was no
conclusive evidence for the existence of the phosphorylated form
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 251–265 doi:10.1242/jcs.154880
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Fig. 1. Evidence of tyrosine phosphorylation of WIP. (A) Schematic of human WIP depicting both known and putative phosphorylation sites and their position
with respect to functional domains. Amino acid sequences representing regions of functional importance are also shown, highlighting the proximity of
respective phosphorylation sites. Serine/threonine residues are in yellow and tyrosine residues in green. (B) Western blots from immunoprecipitation assays
examining the importance of putative WIP serine/threonine phosphorylation sites in determining WASP binding. WIP–EGFP variants encoding serine/threonine
phosphomimetic (serine to aspartic acid) and unphosphorylatable mutations (serine to alanine) were expressed in THP-1 cells by using lentiviral gene
transduction. The exogenously expressed protein was subsequently immunoprecipitated (IP) with anti-GFP antibody to determine the amount of bound
endogenous WASP. Wild-type WIP and WIP lacking the C-terminal WBD (DWBD) were included as positive and negative controls, respectively. (C) Western
blots from immunoprecipitation assays to determine whether the tyrosine residues of WIP represent targets for phosphorylation. WIP–EGFP fusion proteins with
all or individual tyrosine residues replaced with the unphosphorylatable mimic phenylalanine were immunoprecipitated from THP-1 lysates following
pretreatment of cells with pervanadate. The immunoprecipitated wild-type and unphosphorylatable variants of WIP were then probed for tyrosine
phosphorylation by western blotting. (D) Western blots from immunoprecipitation assays examining the importance of WIP tyrosine residues in determining
WASP binding. WIP–EGFP fusions harbouring unphosphorylatable (left panel) and phosphomimetic (right panel) tyrosine mutations were immunoprecipitated
from THP-1 lysates and WASP binding subsequently assessed as in B.
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of this peptide. These results show that cellular WIP is
phosphorylated on Y455 and Y468, which can be readily
detected in situ by mass spectrometry.
WIP tyrosine mutants deficient in WASP binding confer
defects in both podosome assembly and function in
THP-1 cells
To determine the potential effects of tyrosine phosphorylation
of WIP on WASP binding, tyrosine unphosphorylatable and
phosphomimetic variants of WIP–EGFP were immunoprecipitated
from THP-1 lysates and the amount of associated WASP then
determined by western blotting. The unphosphorylatable WIP
variants Y455F, Y468F and Y475F, as well as the triple
unphosphorylatable variant Y455/468/475F all bound strongly to
WASP and could immunoprecipitate WASP to a similar extent as
the wild-type protein (Fig. 1D, left). Cells expressing the
WIP(DWBD)–EGFP mutant provided a negative control,
demonstrating that in the absence of the WBD of WIP, WASP is
undetectable in immunoprecipitates. In contrast to the findings for
the unphosphorylatable mutants, WASP was undetectable in the
immunoprecipitates of cells expressing an EGFP-tagged triple
phosphomimetic mutant WIP Y455E/Y468E/Y475E (Y455/468/
475E) and in trace amounts in cells expressing the WIP(Y468E)–
EGFP mutant, indicating that these mutations in WIP disrupt
WASP binding (Fig. 1D, right). Consistent with these findings,
endogenous WASP levels were increased in cells overexpressing
WIP, but not in cells expressing the Y455/468/475E or Y468E
phosphomimetic mutants or the WASP-binding deficient truncation
mutant WIP(DWBD)–EGFP or EGFP control, indicating that these
phosphomimetic mutants were less efficient at conferring a
protective effect from proteolytic degradation on endogenous
WASP.
In order to determine the role of WIP phosphorylation in
podosome formation, we used a TGFb1-dependent differentiation
of THP-1 cells to macrophages model as previously described
(Monypenny et al., 2011) (supplementary material Fig. S1;
supplementary material Movie 1). Lentiviral-mediated delivery of
short hairpin RNA (shRNA) was used to generate stable WIP-
depleted THP-1 cell lines (supplementary material Fig. S2). Of
five separate WIP-specific shRNA lentiviral vectors assessed in
this study, two were found to reduce WIP levels significantly in
THP-1 cells (supplementary material Fig. S2A). The subsequent
selection of THP-1 shRNA-expressing clones that demonstrated
extremely efficient WIP knockdown (relative expression ,20%
of control) allowed the generation of stable THP-1 cell lines in
which endogenous WIP levels were severely depleted
(supplementary material Fig. S2A, right panel). As shown in
other myeloid cells, loss of WIP expression resulted in a significant
reduction in both the number of cells forming podosomes
(supplementary material Fig. S2B) as well as the number of
podosomes observed per cell (supplementary material Fig. S2C).
Moreover, when a very few ‘podosome-like’ structures were
observed in knockdown cells they were small and far less distinct
than those of control cells (supplementary material Fig. S2C) and
were unable to degrade extracellular matrix (supplementary
material Fig. S2D,E). Expression of a knockdown-resistant
WIP(WT)–EGFP variant in WIP-knockdown THP-1 cells
resulted in the restoration of podosomes in these cells,
confirming that loss of podosome formation could be directly
attributed to loss of endogenous WIP expression (compare
supplementary material Movies 2 and 3).
In addition to the wild-type protein, knockdown-resistant variants
of the Y468E, Y455/468E, Y455/468/475E and Y455/468/475F
WIP phosphomutants [WIP(WT)–EGFPRES, WIP(Y468E)–
EGFPRES, WIP(Y455/468E)–EGFPRES, WIP(Y455/468/475E)–
EGFPRES and WIP(Y455/468/475F)–EGFPRES, respectively]
were also generated and expressed in WIP-knockdown THP-1
cells through lentiviral-mediated gene delivery. The ability of the
wild-type protein and the different mutants to both bind and restore
endogenous WASP levels in THP-1 cells was then assessed
(Fig. 2A). Knockdown-resistant wild-type protein and EGFP alone
provided positive and negative controls, respectively. Rescue
experiments revealed that although knockdown-resistant wild-
type protein and the Y455/468/475F unphosphorylatable WIP
mutant were capable of both binding and restoring endogenous
WASP to a level similar to that found for control cells, the single
Y468E, double Y455/468E and triple Y455/468/475E
phosphomimetic WIP mutants were all defective in WASP
binding as well as their ability to restore endogenous WASP
levels. We also studied podosome dynamics in cells expressing
wild-type WIP or WIP Y468F as a cell readout for the ability of
unphosphorylatable WIP mutants to retain WASP binding
(Fig. 2A,B). Both cell types generated podosomes as predicted
from data in Fig. 2, but their behaviour was markedly different.
Fig. 3A and supplementary material Movies 4 and 5 show that the
WIP Y468F cells appear to have markedly more podosomes than
cells expressing wild-type WIP. We quantified this from live-cell
movies as described in the Materials and Methods to show that the
lifetime of individual podosomes is extended in WIP Y468F cells
(Fig. 3B–D), an observation we confirmed with the triple
Table 1. Identification of two tyrosine phosphorylation sites within the WBD of human WIP
Peptide start-end m/z (z) Sequence Mascot/Andromeda score Rt (min) Phosphate position
227–236 484.7316 (2) (R)GTALGGGSIR(Q) 37/124 28.4 234
259–279 585.0518 (4) (R)ALDDKPPPPPPPVGNRPSIHR(E) 84/144 38.0 276
338–353 845.4147 (2) (R)NLSLSSSTPPLPSPGR(S) 108/219 65.6 340
338–353 845.4153 (2) (R)NLSLSSSTPPLPSPGR(S) 46/193 66.2 342
338–353 845.4145 (2) (R)NLSLSSSTPPLPSPGR(S) 88/115 62.8 350
454–473 819.3910 (3) (R)FYFHPISDLPPPEPYVQTTK(S) 49/184 74.3 455
454–473 819.3919 (3) (R)FYFHPISDLPPPEPYVQTTK(S) 36/n.d. 72.8 468
474–481 461.2611 (2) (K)SYPSKLAR(N) 24/– 17.5 –
Phosphorylation sites in WIP–EGFP, identified by the Mascot and Andromeda search engines from data acquired in linear ion trap (CID) and/or higher energy
collision dissociation (HCD). Phosphorylated amino acids are reported in bold underlined character. The part of the sequence containing the Y475 is included in
a tryptic peptide too small to be detected in the condition chosen for the analysis. However, the peptide (474–481), containing one trypsin miscleavage on K478,
was detected, but there were no evidence for the phosphorylated form of this peptide. Peptide start, end and phosphate position are according to that given for
WAS/WASL-interacting protein family member 1 (UniProt code O43516). Rt, retention time.
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unphosphorylatable mutant (not shown). Thus a direct correlation is
seen between mutation-enforced retention of WIP-WASP binding
and an extended stability of podosome lifetimes.
Interestingly the triple Y455/468/475E mutant was less
efficient in binding WASP than double Y455/468E indicating
that the phosphorylation of the Y475 residue influences WIP–
WASP interaction and might have an endogenous role even
though the mass spectrometry data was unable to confirm
phosphorylation of this residue (Fig. 2A; Table 1). Subsequent
experiments focused on the single Y468E and triple Y455/468/
475E phosphomimetic mutants as they demonstrated the most
dramatic effects.
Further rescue experiments revealed that phosphomimetic
mutants were defective in their ability to restore podosomes in
THP-1 cells (Fig. 2B,C). Both the numbers of cells forming
podosomes as well as the number of podosomes observed per cell
were significantly reduced in WIP-knockdown cells expressing
the triple and single (Y468E) phosphomimetic tyrosine mutants
when compared to WIP-knockdown cells expressing the wild-
type protein (Fig. 2B,C). The Y455/468/475E triple mutant
exhibited a greater defect in its ability to restore podosomes
than the single Y468E mutant, fitting with the residual WASP-
binding ability of this mutant (Fig. 1D). This difference was even
more pronounced when the matrix-degrading potential of cells
expressing these mutants was observed. Quantitative analysis of
matrix degradation revealed that although WIP-knockdown cells
expressing the single Y468E phosphomimetic mutant did exhibit
a significantly impaired ability to degrade matrix, cells
expressing the Y455/468/475E triple phosphomimetic mutant
were completely devoid of any matrix-degrading function
(Fig. 4A–C).
Kinases that regulate tyrosine phosphorylation of WIP
To identify putative kinase(s) responsible for WIP tyrosine
phosphorylation, Merck Millipore’s kinase profiler service was
requested to perform an in vitro screen of candidate tyrosine
kinases using baculovirus-expressed recombinant His-tagged
human WIP as the substrate (Fig. 5A). Although a number of
kinases tested demonstrated some degree of signal above
background, significant phosphorylation activity was observed
for Lck, Hck, Lyn (all members of the Src family) and for Btk, a
Tec family kinase. Although Lck (lymphocyte-specific protein
tyrosine kinase) is not expressed in THP-1 and other monocytic
cells (also confirmed for the THP-1 cells used in this study; data
not shown), both Lyn and Hck are highly expressed in THP-1
cells (our data; not shown). Thus, Btk and these two Src family
kinases represent the most likely candidates for regulating WIP
tyrosine phosphorylation in situ. To further investigate selectivity
of tyrosine kinase action on WIP, we performed knockdown
studies on THP-1 cells. Both Hck and Lyn levels were
successfully reduced below 15% of control levels in single
knockdown clones (Fig. 5B). These cells were able to proliferate
and divide without apparent defect and, when induced by TGFb1,
they assembled podosomes normally (data not shown). In
addition, western blot analyses showed quite distinctly that
despite kinase knockdown, the levels of measured WIP tyrosine
phosphorylation were undiminished compared to controls
(Fig. 5C). Thus knockdown of either Hck or Lyn had no
appreciable phenotype. In contrast, several attempts to generate
cells from Btk-knockdown cultures failed; cells did not
proliferate and cell death rapidly ensued. The lethality of the
Btk knockdown renders the approach unavailable for measuring
the degree of WIP phosphorylation by western blotting.
Fig. 2. Rescue of endogenous WASP and subsequent podosome formation by WIP phophomutant variants. (A) Western blots demonstrating the amount
of endogenous WASP immunoprecipitated by knockdown-resistant WIP–EGFP control and phosphomimetic and unphosphorylatable variants re-expressed in
WIP-knockdown THP-1 cells. (B) Percentage of control and WIP-knockdown THP-1 forming podosomes following re-expression of knockdown-resistant WIP–
EGFP control and phosphomimetic variants. NTC, control shRNA. Data are mean6s.e.m. (C) Box-and-whisker plots summarising podosome counts for those
cells found to form podosomes in B. The box represents the 25th–75th percentiles, and the median is indicated. The whiskers show the 10th–90th percentiles.
Outliers are also indicated. **P,0.01; ***P,0.001; n.s., not significant (Student’s t-test).
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 251–265 doi:10.1242/jcs.154880
255
Jo
ur
na
l o
f C
el
l S
ci
en
ce
We thus chose a second approach based upon pharmacological
inhibitor studies. Inhibition of Src family kinases with PP2
(Fig. 6A) or the dual c-Abl/Src kinase inhibitor Dasatinib
(Fig. 6B) blocked WIP phosphorylation. In contrast treatment
of cells with PP3 (a PP2 analogue used as a negative control for
PP2) or Imatinib (STI-571), an inhibitor of Abl kinase, which was
not identified as a candidate kinase from the Merck in vitro
screen, had no effect on the tyrosine phosphorylation of WIP
(Fig. 6A,C). These data suggested a role for Lyn and/or Hck
while excluding Btk, as it is not a Src kinase. However, a
literature search identified recent findings that PP2 is rather more
promiscuous than generally appreciated and also acts as a good
inhibitor of Btk (Brandvold et al., 2012). Similarly, although
Dasatinib primarily blocks c-Abl and Src kinases, it can also
block Btk (Hantschel et al., 2008). To test the action of Btk
directly, THP-1 cells expressing WIP(WT)–EGFP were treated
with pervanadate and either DMSO control or increasing
concentrations of the highly specific Btk inhibitor PCI-32765
(Ponader et al., 2012) before cell lysis and subsequent
immunoprecipitation of WIP–EGFP to assess tyrosine
phosphorylation. Btk inhibition had an apparently total
inhibitory effect on the tyrosine phosphorylation of WIP at all
pharmacologically relevant (Ponader et al., 2012; Tai et al., 2012)
concentrations of PCI-32765 tested, demonstrating that this kinase
is a key mediator of WIP phosphorylation in these cells (Fig. 6D).
To validate the inhibitor data, we employed an antibody against
phosphorylated Y468 to confirm phosphorylation by Btk on
purified His-tagged wild-type WIP. A clear signal was observed
upon addition of active Btk (Fig. 6E). An anomalous band was also
seen above the WIP signal, which we identify as originating from
the His–Btk itself (supplementary material Fig. S3). When we
performed a similar analysis on cell-derived WIP we found that
WIP–GFP, but not GFP alone or the GFP-tagged triple
unphosphorylatable WIP mutant Y455/468/475F, could be
phosphorylated by Btk (supplementary material Fig. S4). Finally,
we studied the effect of PCI-32765 on THP-1 cells expressing
wild-type WIP treated in the standard manner to generate
podosomes (Fig. 6F). Podosome formation was not grossly
affected but the numbers of podosomes per cell increased after
PCI-32765 treatment. These data correlate with a sustained
functioning of WIP–WASP complexes in the absence of
phosphorylation-mediated dissociation induced by Btk.
DISCUSSION
Until now there has been little evidence for a mechanism to
explain the necessary separation of WIP from WASP that is
Fig. 3. Inhibition of WIP tyrosine phosphorylation increases podosome stability in THP-1. (A) Expression of WIP(Y468F)–EGFP results in increased
podosome stability in THP-1 when compared to wild-type control. The white arrows in the upper panel highlights a region of new podosome formation over time
in a THP-1 cell expressing WIP(WT)–EGFP, whereas the empty arrow highlights a region simultaneously undergoing podosome dissassembly. Podosomes
in a WIP(Y468F)–EGFP-expresing cell (lower panel) remain more stable over time. (B) Box-and-whisker diagrams of podosome adhesion turnover index. The
box represents the 25th–75th percentiles, and the median is indicated. The whiskers show the 10th–90th percentiles. Outliers are also indicated. ***P,0.005
(Mann–Whitney test). (C) Composites for analysis of overall turnover of adhesion. Areas of light grey colour pixels represent dynamic adhesions whereas
areas of dark grey and black colour pixels represent increasingly stable adhesions. (D) Overlap using our pseudocolour method for analysis of adhesion turnover
of the series of three images taken 5 min apart shown in A. Adhesions in red represent adhesions that broke down after the first frame of the timecourse,
whereas green or blue adhesions that were spatially distinct from red adhesions would have formed in the second and third frame, respectively. Stable
adhesions without spatial translocation are shown in white or pink. All images are presented at the same scale as those in Fig. 4.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 251–265 doi:10.1242/jcs.154880
256
Jo
ur
na
l o
f C
el
l S
ci
en
ce
required to facilitate WASP degradation (Chou et al., 2006; de la
Fuente et al., 2007; Konno et al., 2007). Phosphorylation of
serine/threonine residues clustered at functional domains of WIP
have been subject to some analysis but the role of these
phosphosites was not clear. In particular, phosphorylation of
S488 by PKCh was originally proposed to result in dissociation of
the WIP–WASP complex (Sasahara et al., 2002). However,
subsequent studies in both Jurkat cells (Dong et al., 2007) and the
YTS natural killer cell line (Krzewski et al., 2006) have
demonstrated that WIP and WASP remain bound together
following phosphorylation of this residue. We show here that
altering the phosphorylation status of S488 has no measurable
effect on the separation of WIP from WASP. WIP, and in
particular the C-terminal domain encompassing the WBD and the
S488 residue, is known to be an intrinsically disordered protein
(Haba et al., 2013), so it is possible that phosphorylation of S488
would result in a subtle shifting of the association between
WIP and WASP. Recent work using a triple-colour FRET
methodology has demonstrated that serine phosphorylation events
can modify the spatial interaction of WIP–WASP interacting
domains without driving complete protein separation (Fried et al.,
2014). We also screened other candidate serine/threonine residues
identified in silico as potential phosphorylation targets (Shu et al.,
2004) and in all cases found no effects on WIP–WASP
association (Fig. 1).
In contrast to the negative findings on serine and threonine
residues, we demonstrate for the first time tyrosine
phosphorylation of WIP. Human WIP contains three tyrosine
residues that are located exclusively within the WBD, within or
adjacent to sequences known to be important for WIP–WASP
association (Volkman et al., 2002; Zettl and Way, 2002; Peterson
et al., 2007). Y455 lies between two phenylalanine residues
identified as being crucial for WIP binding to the ubiquitously
expressed N-WASP and thus presumably also for binding
hematopoietic-specific WASP (Zettl and Way, 2002; Peterson
et al., 2007). The Y468 residue lies directly downstream of the
proline-rich DLPPEP motif (residues 461–467) postulated to
interact directly with the EVH1 domain of N-WASP and WASP.
The EVH1 domain (also called WH1 domain) is implicated in
actin remodelling through its binding to proline-rich regions of its
target partner proteins. The best-characterized EVH1-domain-
binding partners are members of the verprolin family of proteins.
Fig. 4. Evaluation of the ability of wild-type and phosphomutant forms of WIP to rescue podosome formation and function in WIP-knockdown cells.
(A) Widefield images of fixed WIP-knockdown THP-1 cells re-expressing either knockdown-resistant WIP(WT)–EGFP or the triple phosphomimetic mutant WIP
(Y455/468/475E)–EGFP. Additional vinculin staining demonstrates podosome rescue in cells re-expressing wild-type WIP but not the triple tyrosine
phosphomimetic mutant. Insets (yellow boxes) are enlarged to highlight vinculin rings of podosomes with WIP at the core in the case of wild-type protein
expression, and focal-adhesion-like structures lacking any significant WIP colocalisation in the case of triple tyrosine phosphomimetic mutant expression.
(B) Statistical evaluation of the percentage of WIP-knockdown THP-1 cells degrading a TRITC-labelled gelatin matrix following expression of indicated
constructs. Data are mean6s.e.m. *P,0.05, ***P,0.001. (C) Representative confocal images from gelatin degradation assays used for the statistical analysis
summarised in B. Gelatin assays were performed to evaluate the ability of WIP-knockdown THP-1 cells to degrade the underlying TRITC-labelled gelatin matrix
following re-expression of the indicated knockdown-resistant constructs. Scale bars: 5 mm.
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These include WIP, CR16 and WICH/WIRE (WIP and CR16
homologous protein/WIP related protein) (Anto´n et al., 2007).
Residue Y475 lies immediately upstream of the conserved
PSKxxR motif (residues 476–481) believed to interact with
acidic residues within the N-WASP/WASP EVH1 domain
(Volkman et al., 2002). Our initial in silico analysis identified
Y468 as a putative target for receptor tyrosine kinases and given
the significance of the position of this and other tyrosine residues
with respect to important subdomains within the WBD of WIP,
we set out to discover whether they represented targets for
phosphorylation.
Mass spectrometry demonstrated that Y455 and Y468 are
phosphorylated on human WT WIP–EGFP expressed and
subsequently purified from human myeloid cells. Regarding
tyrosine 475, technical limitations do not allow us to confirm
with enough certainty its phosphorylation state. Phosphomimetic
mutations of the three tyrosine residues completely abolish the
WIP–WASP interaction, while the single phosphomimetic mutant
of the central Y468 residue greatly perturbs this interaction.
Using our THP-1 model in which TGFb1-induced differentiation
results in cell adhesion, podosome production and associated
matrix degradation (Monypenny et al., 2011), we demonstrate a
role for these tyrosine phosphorylation sites in the regulation of
podosome function. Knockdown of endogenous WIP in THP-1
inhibits both podosome formation and function in these cells in a
manner reminiscent of the data from WIP-null mouse dendritic
Fig. 5. Tec family kinases involved in WIP phosphorylation. (A) An in vitro kinase assay using His6–WIP (human, full length) was performed by Merck
Millipore following their standard protocols for the KinaseProfilerTM. The histogram presents the kinase screen data. A number of kinases tested were shown to
have some degree of signal above background indicative of phosphorylation of WIP. The highest responses were measured for the Tec family kinase Btk
followed by Lyn and Lck. Assays were performed in duplicate with acid blanks as a negative control. Data are mean6s.d. (B) Evaluation of the efficacy of
five non-overlapping Hck and Lyn shRNAs. THP-1 cells were transduced with lentivirus, subjected to puromycin selection, and finally assayed for
endogenous Hck and Lyn expression. b-tubulin was used as a loading control. (C) Immunoprecipitation (IP) was performed in Hck- and Lyn-depleted cells
overexpressing WIP–EGFP using an anti-GFP antibody to assess the level of WIP phosphorylation. Membranes were blotted with the anti-phosphorylated
tyrosine (pTyrosine, 4G10) antibody and anti-EGFP antibody.
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cells (Chou et al., 2006). Re-expression of knockdown resistant
wild-type WIP results in the efficient restoration of functional
podosomes. Expression of the triple tyrosine phosphomimetic WIP
mutant results in only a minimal salvage of severely disorganised
structures that also lack any matrix-degradation functionality.
We consequently propose that tyrosine phosphorylation of
WIP provides a novel mechanism for regulating WIP–WASP
association, and thereby podosome turnover and function in
leukocytes.
Until now, mechanisms that directly control WIP–WASP
association have remained elusive. The role of WASP
phosphorylation in the regulation of cytoskeletal dynamics,
podosome formation, function and cell behaviour has been the
focus of far greater attention in recent years and a number of
phosphorylation sites have now been identified that influence
WASP function and turnover. For instance, tyrosine 291 (293 in
mouse) of WASP seems to regulate both protein turnover as well
as its ability to induce Arp2/3-dependent actin polymerisation
(Blundell et al., 2009; Macpherson et al., 2012), while
constitutive phosphorylation of WASP at serines 483 and 484
appear to be required for Arp2/3 association (Cory et al., 2003). A
phosphomimetic mutant of tyrosine 291 enhances WASP-
mediated actin polymerisation when compared to wild-type
protein in an in vitro bead assay, while resting levels of
filamentous actin are increased in cells expressing this mutant
when compared to wild-type protein. However, murine knock-in
models also reveal that phosphomimetic Y293 WASP is expressed
at far lower levels than wild-type protein, an observation that can
be partially reversed through inhibition of calpain (Macpherson
et al., 2012) and/or the proteasome (Blundell et al., 2009)
suggesting that phosphorylation of this site also targets WASP
for degradation. However, the phosphomimetic versions of WASP
Y291 bound to WIP with the same affinity as normal WASP
(Blundell et al., 2009; Macpherson et al., 2012) indicating that an
unidentified mechanism regulated the full dissociation of WIP
from WASP and the latter’s complete degradation. Therefore an
Fig. 6. Identification of Btk as a potent kinase for WIP tyrosine phosphorylation. Inhibition of WIP–EGFP tyrosine phosphorylation. Total protein lysates
were prepared from THP-1 cells that were stably transfected with wild-type WIP–EGFP and treated with either (A) PP2 or PP3, (B) Dasatinib, (C) STI-571
or (D) PCI-32765 at the concentration specified on the blots for 2 h before pervanadate treatment for 30 min. In all cases WIP–EGFP was immunoprecipitated
(IP) from cell lysates using anti-EGFP antibody and membranes subsequently blotted with the anti-phosphorylated tyrosine (pTyrosine, 4G10) antibody, anti-
EGFP antibody and anti-b-tubulin antibody. (E) In vitro kinase assay. Western blot analysis of recombinant His–WIP that was pre-incubated with resin and
then treated with or without recombinant His-tagged active Btk. Membranes were blotted with WIP antibody and pY468 polyclonal antibody. Postions of His-
tagged WIP, Btk and phosphorylated WIP are indicated on the right of the panels. (F) Effect of PCI treatment on podosome stability in THP-1 cells. Left,
widefield fluorescence images of TGFb-differentiated WIP(WT)–EGFP expressing THP-1 cells treated with either PCI (1 mM) or DMSO carrier control. Right,
PCI-32765 (PCI) treatment increases the average podosome numbers in THP-1 when compared to control cells treated with DMSO carrier. Data are
mean6s.e.m. **P,0.01 (Student’s t-test). Scale bars: 20 mm.
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intricate mechanism seems to be in place to balance WASP
activation with its subsequent degradation. WIP has previously been
reported to protect WASP from degradation (Tsuboi, 2007; Reicher
et al., 2012; Chou et al., 2006; de la Fuente et al., 2007), and given
that we now show that tyrosine phosphomimics of WIP both disrupt
WIP–WASP association and result in a depletion of endogenous
WASP levels, WIP tyrosine phosphorylation provides yet another
mechanism for regulating WASP-dependent cytoskeletal
rearrangements. Our current and previous work suggests that WIP
may complex with phosphorylated, active WASP (Tsuboi and
Meerloo, 2007; de la Fuente et al., 2007; Macpherson et al., 2012;
Tsuboi, 2007) enabling it to orchestrate Arp2/3-dependent actin
polymerisation events while protected from the degradation
machinery (Watanabe et al., 2013). In this latter case WIP
tyrosine phosphorylation would therefore provide the signal for
the complete release of active WASP, resulting in its subsequent
breakdown through both calpain and the ubiquitin-proteasome
pathways and consequently termination of Arp2/3 mediated actin
filament generation. Accordingly, the rapid breakdown of
podosomes required in rapidly migrating macrophages and
dendritic cells (Calle et al., 2008; Macpherson et al., 2012) would
be mediated through tyrosine phosphorylation of WIP.
It is well known that members of the Src family kinases, and in
particular Hck, can have significant effects on leukocyte cell
morphology and movements, both in two-dimensional and three-
dimensional environments (Suen et al., 1999; Guiet et al., 2008;
Cougoule et al., 2010). Hck can also activate WASP through
phosphorylation of Y291, leading to Arp2/3 binding and actin
filament assembly (Cory et al., 2002). Hck was also identified as
a WIP target, but only through a screen of Hck SH3 domain
ligands (Scott et al., 2002). Based on these and other reports, it
would be utilitarian to expect Hck to be the key kinase regulating
podosome formation through a WIP–WASP pathway. Our
findings from both the Src inhibitor PP2 study and our kinase
screen all pointed to this conclusion until confounded by the
finding that Hck (and Lyn) knockdown cells could still generate
normal podosomes and exhibited control levels of WIP tyrosine
phosphorylation. Only a re-examination of the kinase screen
results and the inhibitor experiments described above led us
to discover that the Tec family kinase Btk appears to be
the most significant kinase controlling the levels of WIP
tyrosine phosphorylation. We confirmed that Btk can indeed
phosphorylate Y468 of baculovirus-generated human His-tagged
WIP (Fig. 6E), but that this is more difficult to show in cell
extracts where WIP would be purified along with cellular WASP
(supplementary material Fig. S4). We conclude that the WIP–
WASP binding in our cell extract is often so strong that we cannot
disturb the interaction sufficiently to allow Btk access the
tyrosine residues. It might well be that earlier events that are
reported to subtly re-arrange the WIP–WASP conformation
(Fried et al., 2014) are required to expose Y468 for Btk action.
Btk has been shown to associate directly with and
phosphorylate WASP (Guinamard et al., 1998). Btk-null
mutations have been reported in mice (XID) and in humans
with X-linked agammaglobulinaemia (XLA). In both cases
profound deficiencies in B-cell development and function has
been observed. In osteoclasts derived from human XLA patients,
podosome-based ring formation, essential for effectively
Fig. 7. A pathway to WASP regulation. A model of the sequence through which WASP is rapidly activated and then inactivated in zones of podosome core
assembly. WASP is initially held in an autoinhibited hairpin conformation while tightly linked to WIP. Following WASP activation through the binding of Cdc42 and
other agents (Thrasher, 2002), Arp2/3 is bound to the freed C-terminal VCA domain where it facilitates actin filament assembly to initiate podosome core
formation (Calle et al., 2008). Tyrosine phosphorylation of WIP within the WBD is sufficient to break the physical association of WIP and WASP, leaving WASP
vulnerable to degradation through calpain (Chou et al., 2006; Macpherson et al., 2012) and/or ubiquitin pathways (Blundell et al., 2009; Reicher et al., 2012). The
resulting dendritic filament array would then be vulnerable to dissolution through the action of cofilin or could be stabilised by replacement of WASP
with cortactin.
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resorbing calcified matrices, has been shown to be impaired
(Danks et al., 2011). Similarly, the same effects are observed by
treating osteoclasts with pharmacological inhibitors of Btk, both in
vitro and in vivo (Tai et al., 2012). Furthermore, a WIP–WASP–Btk
complex has been shown to be necessary for the activation of the
TLR4 signal complex in LPS-stimulated macrophages (Sakuma
et al., 2012). Based on previous reports and the present data we
suggest that Btk can induce WASP activation and also facilitates its
subsequent inactivation through WIP phosphorylation.
Taken together, these findings demonstrate that tyrosine
phosphorylation of WIP provides a new mechanism for
regulating WIP–WASP dissociation and consequent degradation
of WASP (Fig. 7). The general significance of these findings
might also extend to WIP–N-WASP interactions that occur
ubiquitously (Anto´n et al., 2007), to regulated cell migration
(Ban˜o´n-Rodrı´guez et al., 2013) and, in particular, the process of
invadopodia formation in some metastatic carcinomas (Garcı´a
et al., 2012; Yu et al., 2012).
The identification of Btk as a key mediator of WIP tyrosine
phosphorylation in THP-1 cells provides important new insights
into the regulatory pathways that lie upstream of WIP–WASP and
consequently on podosome formation in myeloid cells and its
clinical significance (Tai et al., 2012). Future work will attempt to
discover the upstream signalling cascade leading to Btk activation
with an emphasis on the spatial context of podosome breakdown.
It would also be informative to know something of the
phosphatase(s) regulating Btk in this context given that
constitutive phosphorylation of WIP would greatly hinder the
WASP activity necessary for podosome initiation and assembly.
MATERIALS AND METHODS
Cell culture
THP-1 cells (a human monocytic cell line) were purchased from the
ATCC cell bank. Cells were maintained as suspension cultures in RPMI
supplemented with 10% fetal calf serum (FCS). To induce podosome
formation, cells were seeded in culture medium supplemented with 1 ng/
ml recombinant human TGFb1 (R&D Systems) either on coverslips or
60-mm tissue culture dishes, both coated with 10 mg/ml bovine
fibronectin (Sigma). Cells were then left for 24 h to attach and form
podosomes prior to subsequent experimentation.
Generation of lentiviral vectors
cDNA encoding wild-type human WIP was amplified by PCR from
pcDNA3/hWIP template plasmid and subcloned into the pCR-BLUNT
vector (Invitrogen) where subsequent unphosphorylatable and phosphomimetic
mutations for the relevant tyrosine, serine and threonine residues were
incorporated using the QuikChange XL site-directed mutagenesis kit
(Stratagene). C-terminal EGFP fusions of WIP and the various WIP
mutants were generated by an intermediate subcloning step and the
complete WIP–EGFP fusion construct then inserted into the multiple
cloning site of the pHR’SINcPPT-SFFV (pLNT/Sffv) lentiviral transfer
vector. The DWBD WIP truncation mutant lacking residues 450–503 (the
WASP-binding domain) was generated by PCR using the same
intermediate subcloning procedure. Lentiviral constructs were then
sequenced and subsequently used for virus production (see below). For
rescue experiments, three separate single-base silent mutations were
introduced into the coding sequence of human WIP–EGFP and the
associated phospho-mutants to confer resistance to shRNA-mediated
knockdown following expression in THP-1 WIP-knockdown cell lines.
These mutations, which reside within the human WIP sequence targeted by
the Sigma Mission NM_003387.3-266s1c1 (#266) shRNA lentiviral vector,
were introduced simultaneously through site-directed mutagenesis using a
single primer (59-GAAGTGCACCAATACTGGATAAGCCGAAAGGA-
GCTGGTGCTGGAG-39) resulting in the following nucleotide alterations:
bp 180, C to A; bp 183, A to G; and bp 186, T to G.
The mCherry–talin truncation construct was generated by PCR and
subsequent subcloning as follows: PCR was used to amplify cDNA
encoding residues 1975–2541 of human talin from the template plasmid
(gift from Maddy Parsons, King’s College London, UK) and cloned via
the pCR-BLUNT vector into the MCS of the pLNT/Sffv-mCherry-MCS
vector generating the mCherry–talin (1975–2541) lentiviral expression
construct.
Lentiviral gene transduction
VSV-G pseudotyped lentivirus encoding fluorescent fusion constructs or
shRNAs were packaged in HEK-293T cells. Packaging cells were
transiently transfected with the pCMVDR8.91 and pMD.G accessory
plasmids along with the given transfer vector: either pLNT/Sffv encoding
fluorescent fusion proteins or pLKO.puro encoding shRNAs.
Supernatants containing lentivirus were harvested 48 h later, 0.45 mm-
filtered and stored at 280 C˚ for future use. THP-1 cells were incubated
with lentiviral supernatants in 12-well plates for 24 h and then washed
thoroughly before expanding cultures. In the case of shRNA-encoding
lentivirus, cells were transferred to medium supplemented with 1 mg/ml
puromycin at 56 h post infection to ensure selection of only those cells
that had successfully incorporated the lentiviral DNA. shRNA-encoding
lentiviral vectors were from the MissionH shRNA plasmid DNA bank
(Sigma). Clone IDs for WIP-specific shRNAs lentiviral plasmids used in
this study were NM_003387.3-266s1c1 (#266), NM_003387.3-1388s1c1
(#1388), NM_003387.3-151s1c1 (#151), NM_003387.3-676s1c1 (#676),
and NM_003387.3-1430s1c1 (#1430). Clone IDs for Hck-specific
shRNAs lentiviral plasmids used were NM_002110.2-417s21c1,
NM_002110.2-1735s21c1, NM_002110.2-1930s21c1, NM_002110.2-
1352s21c1, NM_002110.2-1285s21c1. Clone IDs for Lyn-specific
shRNAs lentiviral used were: NM_002350.2-2863s21c1, NM_002350.2-
341s21c1, NM_002350.2-318s21c1, NM_002350.2-889s21c1, NM_002350.2-
1570s21c1. The non-targeting control pLKO.puro plasmid (NTC) was a
gift from Ester Martin (Addgene; ID 1864).
Immunoprecipitation and western blot studies
For immunoprecipitation studies, THP-1 cells were seeded on
fibronectin-coated dishes in the presence of TGFb1 for 24 h to induce
differentiation and podosome formation as described above. Cells were
then lysed in 1 ml ice cold lysis buffer containing 150 mM NaCl, 1%
Triton X-100, 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 100 mM NaVO4,
50 mM NaF, and protease inhibitor mix (Roche). Lysates were clarified
by centrifugation, pre-cleared for 30 min with IgG–agarose beads, and
then incubated with primary antibody for 60 min at 4 C˚ with rotation.
Antibody was then captured by addition of Protein A/G agarose beads
(Alpha Diagnostic) followed by an additional 60 min incubation with
rotation at 4 C˚. Finally beads were washed once with lysis buffer and
then three times with wash buffer (lysis buffer containing 500 mM NaCl)
before re-suspending beads in sample buffer. In cases where tyrosine
phosphorylation of immunoprecipitates was analysed, cells were pre-
treated with 12 mM pervanadate for 20 min prior to lysis.
After treatment, samples for phospho-mapping analysis were incubated
with GFP-TRAP-A beads (ChromoTek, Martinsried, Germany) for 2 h
on a rotor at 4 C˚. GFP or GFP fusion proteins were pulled-down by
centrifugation at 3000 g for 2 min at 4 C˚. Beads where then washed three
times using immunoprecipitation lysis buffer before being snap frozen.
Antibodies used for immunoprecipitation and western blotting were as
follows. Goat polyclonal anti-WIP (G-20) and mouse monoclonal anti-
WASP (Clone B-9) were from Santa Cruz Biotechnology. Rabbit
polyclonal and mouse monoclonal anti-EGFP were from MBL (#598)
and Roche (#11-814-460-001), respectively. Mouse monoclonals against
GAPDH (clone 6C5) and phosphotyrosine (4G10 Platinum) were from
Millipore. For detection of phosphotyrosine in immunoblots, 100 mM
NaVO4 was included during membrane blocking and primary and
secondary antibody incubation stages.
For the quantification of protein bands in immunoblots, images were
processed in ImageJ as follows. Images were inverted, processed to
subtract background using default ImageJ settings, and the integrated
density function then used to quantify protein band intensity. Protein
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 251–265 doi:10.1242/jcs.154880
261
Jo
ur
na
l o
f C
el
l S
ci
en
ce
bands were then normalised to that of their corresponding GAPDH
loading controls. The level of normalised protein expression for each lane
of a blot was expressed as a percentage of that for the control NTC
shRNA lane.
Live-cell imaging
Wide-field studies were conducted using an Olympus IX81 wide-field
inverted microscope equipped with an environment chamber accurately
maintained at 37 C˚. All imaging was conducted using 1006, NA 1.4
objective and excitation and emission filter wheels (Sutter) equipped
with filters optimised for EGFP and mCherry epifluorescence. Image
acquisition was controlled by Metamorph imaging software (Universal
Imaging). In order to monitor podosome turnover time-lapse imaging was
conducted over a 30-min period with fluorescence images acquired at
30-s intervals.
Analysis of adhesion turnover
The podosome turnover in THP-1 cells expressing EGFP constructs was
performed by visualising the GFP signal using an IX71 Olympus
inverted epifluorescence microscope and images were acquired every
30 s. Micrographs were processed using Adobe PhotoshopH version 7.0
to threshold the podosome cores in the cells. To analyse the persistence
of the spatial localisation of podosome cores, five interference reflection
microscopy (IRM) images taken 5 min apart were used. Each image was
thresholded to produce white adhesions on a black background and
then inverted as black adhesions on a white background. Next, the
black value of each image was divided by five to obtain dark gray
corresponding to adhesions (i.e. 256/5 on the scale of 1–256). The
images were then overlapped using the ‘difference’ function in Adobe
Photoshop. We thus obtained a composite image with five relevant grey
levels. The lightest grey level represented pixels that were present in one
of the five images (adhesion points last for less than 5 min), and the
darkest grey level represented pixels that were present in five out of five
images (i.e. adhesion points last for 20 min). Therefore, the areas of
lighter grey colour pixels represent dynamic adhesions whereas areas of
dark grey and black colour pixels represent increasingly stable
adhesions during the selected time course of measurement. Using
MathematicaTM 5.2 notebooks (Macpherson et al., 2012), we could
quantify the percentage of pixels corresponding to each grey level per
image, which allowed us to calculate a turnover index by dividing the
percentage of pixels present in one or two frames by the percentage of
pixels present in four or five frames (Macpherson et al., 2012). Thus, a
ratio of unstable adhesion over stable adhesion in each live cell was
obtained. A higher value of the turnover index represents more dynamic
cell adhesion. A Mann–Whitney test was used to assess the significance
of experimental results.
Immunocytochemistry
THP-1 cells were seeded on fibronectin-coated coverslips (10 mg/ml) in
growth medium supplemented with 1 ng/ml TGFb1 and cultured for
up to 24 h. Cells were then fixed with 3.7% paraformaldehyde,
permeabilised with 0.01% Triton X-100, and blocked in 3% BSA in
PBS before incubation with primary antibodies. Filamentous actin was
stained using Alexa-Fluor-465-conjugated phalloidin (Molecular Probes),
which was included during the primary antibody incubation step.
Vinculin was labelled using the mouse monoclonal clone hVIN-1
(Sigma) and Alexa-Fluor-568-conjugated donkey anti-mouse secondary
antibody (Molecular Probes). Coverslips were mounted on slides using
Prolong Gold (Invitrogen) and imaged using a Zeiss LSM 510 inverted
confocal microscope using a 636 Plan Fluor objective.
Podosome counting
For quantification of cells with or without podosomes, or podosome
numbers per cell, a minimum of three repeat assays were scored with a
minimum of 40 cells counted in fixed preparations from each experiment.
ImageJ was used to acquire counts and a Student’s t-test performed on
the resulting combined data sets. A cell was considered to contain
podosomes if it contained more than one identifiable structure.
Matrix degradation assay
Preparation of fluorescent gelatin
2 mg/ml of gelatin was dissolved in a solution containing 61 mM of
NaCl and 50 mM sodium borohydrate (Na2B4O7) (pH 9.3) (Sigma-
Aldrich) and then incubated at 37 C˚ for 1 h. After dissolution, 2 mg of
Rhodamine (Sigma-Aldrich) was added and mixed for 2 h in darkness.
This mixture was then dialysed overnight at room temperature in PBS in
complete darkness. Dialysis was repeated for 2 days with two buffer
changes per day. After addition of 2% (w/v) sucrose a quick spin was
performed to remove insoluble material and small aliquots were stored in
the dark at 4 C˚.
Preparation of fluorescent-gelatin-coated coverslips
Prior to coating, 13-mm glass coverslips were sterilized in 70% ethanol
for 30 min at room temperature and rinsed in 99% ethanol. Air-dried
coverslips were then coated with warm Rhodamine-conjugated gelatin,
using around 200 ml per 13-mm round coverslips to cover the surface for
5 min. Each coverslip was inverted onto a 200 ml volume of 0.5% ice-
cold glutaraldehyde in PBS held on a parafilm support. After 15 min in
the dark at room temperature, each coverslip was then transferred to a
multi-well dish with the coated side up and gently washed three times
with PBS. Coverslips were subsequently incubated with 1 ml of sodium
borohydride (5 mg/ml) in PBS for 3 min at room temperature and
washed three times with PBS. Finally coverslips were sterilized again in
70% ethanol for 5 min, dried for 10–15 min under a sterile hood and then
quenched in complete medium for 1 h at 37 C˚.
Procedure
26105 cells were cultured on gelatin-coated coverslips and stimulated
with 1 ng/ml of human recombinant TGFb for 15–24 h, then fixed in
3.7% PFA and processed for immunofluorescence as described above.
For quantification of matrix degradation, cells were imaged using a Zeiss
LSM 510 inverted confocal microscope. Five random fields at a 1006
(Plan fluor objective) magnification were imaged. For each experimental
condition, cells exhibiting gelatin degradation immediately beneath a cell
were scored. The percentage of cells showing gelatin degradation activity
was calculated as an indicator of podosome functionality. The data shown
are a mean of three separate experiments compared using Student’s t-test.
Mass spectrometry
Sample preparation
For phospho-mapping analysis, 107 THP-1 cells overexpressing
WIP–EGFP were seeded on fibronectin-coated dishes in the presence
of 1 ng/ml of TGFb for 24 h. Cells were pre-treated with 12 mM
pervanadate for 20 min prior to lysis to inhibit endogenous phosphatases.
To perform phosphorylation site analysis on an isolated protein,
endogenous phosphatases had to be kept inactive before purification by
immunoprecipitation. After treatment samples were lysed using 1 ml of
the lysis buffer: 150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1 mM
EGTA, 10 mM sodium b-glycerophosphate, 50 mM NaF, 5 mM sodium
pyrophosphate, 1 mM NaOV, 16 Triton X-100, proteinase inhibitor
tablet, 0.27 M sucrose, 1 mM DTT. Lysates were incubated with 15 ml of
GFP-TRAP-A beads (ChromoTek, Martinsried, Germany) for 2 h on a
rotor at 4 C˚. GFP or GFP fusion proteins were pulled-down by
centrifugation at 3000 g for 2 min at 4 C˚. Beads were then washed
three times using immunoprecipitation lysis buffer before being snap
frozen.
Proteolytic digestion of proteins ‘in gel’
Immunoprecipitated WIP–EGFP was eluted from the beads using 1%
SDS, separated by SDS-PAGE gels and visualized with Colloidal
Coomassie Blue. The band containing WIP–EGFP fusion protein was
excised from the gel and digested with trypsin.
Liquid chromatography–mass spectrometry
The tryptic digest obtained was separated by nanoscale C18 reverse-
phase liquid chromatography [EASY-nLC II (Thermo Fisher Scientific)]
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coupled to a Linear Trap Quadrupole (LTQ) Orbitrap Velos mass
spectrometer (Thermo Fisher Scientific). Samples were loaded on a pre-
column (C-18 Biosphere 5 mm, 120 A˚–200 mm60.2 cm) for desalting,
and subsequently eluted, at a flow of 0.6 ml/min, into an analytical
column (C-18 Biosphere 5 mm, 120 A˚–100 mm615 cm).
The eluting peptide solutions were electrosprayed into the mass
spectrometer via a nanoelectrospray ion source. The mass spectrometer
was operated in positive ion mode and used in data-dependent acquisition
mode. A full scan (FT-MS) was acquired with resolution of 30,000 over
mass range of 350–2000 amu, and the top ten most intense ions were
selected for fragmentation using both available fragmentation modes:
linear ion trap (CID) and higher energy collision dissociation (HCD) in
two different acquisitions.
To improve the fragmentation of phosphopeptides in CID mode, the
‘multistage activation algorithm’ in the Xcalibur software was enabled.
Fragmentation spectra in HCD were acquired in the FTMS analyser at a
resolution of 7500 in centroid mode. Normalized collision energy used
was 35 for both multistage activation CID and HCD methods. The ‘lock
mass’ function (lock mass5445.120036 Da) was enabled for MS and
MS/MS HCD scan modes.
Data analysis
The raw data obtained from HCD and multistage activation CID
acquisitions were processed and pooled with Raw2MSN and all MS/MS
samples were analysed using Mascot (Matrix Science, London, UK;
version 2.3.02), querying SwissProt database (release 2011_11, selected
for Homo sapiens, 20249 entries) using the digestion enzyme trypsin and
allowing for two miscleavages.
Mascot was searched with a fragment ion mass tolerance of 0.5 Da and
a parent ion tolerance of 10 ppm. The iodoacetamide derivative of
cysteine was specified in Mascot as a fixed modification. Oxidation of
methionine and phosphorylation of serine, threonine and tyrosine were
specified in Mascot as variable modifications.
Scaffold (version 3.1.2, Proteome Software Inc., Portland, OR) was used
to validate MS/MS-based peptide and protein identifications. Peptide
identifications were accepted if they could be established at greater than
95.0% probability as specified by the Peptide Prophet algorithm, resulting
in a peptide false discovery rate (FDR) of 0.7%. Additional data processing
was carried out using Maxquant/Andromeda (version 1.2.0.18). The search
engine was forced to consider unlabelled peptides by setting the
multiplicity value to 1. Fixed and variable modifications, enzyme and
numbers of miscleavages were the same chosen previously for Mascot. The
peptide, protein and site FDR was set at 0.01; peptides identified with less
than six amino acid residues were not included in the results.
Kinase profiling assay
Kinase assays were conducted using Merck Millipore’s FlexLab service
based on the protocols detailed at http://www.millipore.com/
techpublications/tech1/pf3036.
Inhibitor assays
THP-1 cells were seeded on fibronectin-coated 60-mm diameter dishes at
a density of 56106 cells/ml and treated with 2 ng/ml of TGFb for 15 to
24 h. Podosome-forming cells were treated for 2 h with the indicated
concentrations of the following inhibitors: PP2 (Tocris Bioscience), PP3
(Tocris Bioscience), Dasatinib (Selleckchem.com) PCI-32765 (Selleckchem.
com) and STI-571 (Selleckchem.com). Cells were then treated with 12 mM
pervanadate for 30 min prior to lysis. Cells were washed with ice-cold PBS
and lysed using 1 ml lysis buffer supplemented with sodium fluoride, sodium
pyrophosphate, sodium orthovanadate and sodium glycerophosphate. Pre-
cleared lysates were incubated with 15 ml of GFP-TRAP-A beads
(ChromoTek, Martinsried, Germany) for 2 h on a rotor at 4 C˚. EGFP or
EGFP fusion proteins were immunoprecipitated and beads subsequently
collected by centrifugation at 3000 g for 2 min at 4 C˚. Beads where then
washed three times using immunoprecipitation lysis buffer before loading
onto polyacrylamid gels. Nitrocellulose membrane were then probed with
the anti-phosphorylated-tyrosine 4G10 (Millipore), anti-b-tubulin (Sigma-
Aldrich) and anti-EGFP (Roche) antibodies.
In vitro Btk phosphorylation assay
Aliquots of 3 mg of purified recombinant His–WIP (Merck-Millipore)
were incubated with Ni-NTA resin (Qiagen) in wash buffer (50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 25 mM imidazole pH 8.0, 0.1% Triton X-
100) for 1 h at 4 C˚ with rotation. The resin was washed three times in
wash buffer and once in kinase buffer (25 mM MOPS pH 7.2, 12.5 mM
glycerol 2-phosphate, 25 mM MgCl2, 5 mM EGTA, 0.25 Mm DTT,
100 mM ATP). The resin was then incubated with 20 ml of kinase buffer
containing 100 ng of His-tagged active Btk (Sigma) for 1.5 h at 30 C˚.
The resin was washed three times in wash buffer before boiled with FSB
and subjected to western blot analysis.
For the Btk phosphorylation assay using the overexpressed EGFP-
tagged proteins from THP-1 cells, immunoprecipitation was performed
using GFP-TRAP-A beads. Five million THP-1 cells that contain either
overexpressed EGFP, EGFP-tagged WIP (WT) or WIP(Y455/468/475F)
were washed two times with PBSA at 4 C˚ and resuspended in 0.7 ml
culture cell lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM
Na3VO4, 50 mM NaF, 5% glycerol, 1% Triton X-100, 16 protease
inhibitors). Cells were disrupted by vigorous pipetting and the resulting
cell lysate was cleared of nuclei and membranes by centrifugation at
16,100 g for 10 min at 4 C˚. Clarified cell lysates were then incubated
with GFP-TFAP-A beads for 1 h at 4 C˚ with rotation. The beads were
washed three times in cell lysis buffer and once in kinase buffer (25 mM
MOPS pH 7.2, 12.5 mM glycerol 2-phosphate, 25 mM MgCl2, 5 mM
EGTA, 0.25 Mm DTT, 100 mM ATP) before being incubated with 20 ml
of kinase buffer containing 20 ng of His-tagged active Btk for 30 min at
30 C˚. The beads were then washed three times in cell lysis buffer before
boiled with final sample buffer (FSB; 60 mM Tris-HCl pH 6.8, 2% SDS,
10% glycerol, 5% b-mercaptoethanol, 0.01% Bromophenol Blue and
1 mM Na3VO4) and subjected to western blot analysis.
The pY468 rabbit polyclonal antibody that was used in these assays
was generated against the peptide PEP[pY]VQTTKSYPSKC of human
WIP, a service provided by GenScript.
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